Anzeige
Mehr »
Lynx Broker
Login
Montag, 14.10.2019 Börsentäglich über 12.000 News von 613 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14M2J ISIN: IE00BTN1Y115 Ticker-Symbol: 2M6 
Tradegate
11.10.19
18:55 Uhr
97,62 Euro
+0,04
+0,04 %
1-Jahres-Chart
MEDTRONIC PLC Chart 1 Jahr
5-Tage-Chart
MEDTRONIC PLC 5-Tage-Chart
RealtimeGeldBriefZeit
97,18
97,96
13.10.
97,10
97,82
11.10.

Aktuelle News zur MEDTRONIC Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrMedtronic to Buy Israeli Catheter Developer AV Medical for $30 Million2
Börsennews zur MEDTRONIC Aktie und weiteren Hot Stocks erhalten
DoMedtronic puts $50m into Puerto Rico operations1
DoMedtronic Submits Two Pelvic Health Devices for FDA's PMA1
MiFDA classifies Medtronic catheter recall as Class I3
MiMedtronic plc: FDA Classifies Medtronic Sherpa Delivery Catheter Field Action Initiated in March 2019 as Class I Recall348DUBLIN, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) has classified the company's voluntary field action initiated in March...
► Artikel lesen
MiMedtronic Gets FDA's Breakthrough Device Nod for Valiant TAAA-
MiMedtronic Recalls 6 French Sherpa NX Active Guide Catheters203FRIDLEY (dpa-AFX) - Medical device company Medtronic, on Tuesday, recalled all models of its 6 French Sherpa NX active guide catheters due to separation and fragmentation issues.According...
► Artikel lesen
DiMedtronic nets FDA breakthrough label for aortic aneurysm-sealing stent system1
DiMedtronic recalls 6 French Sherpa NX active guide catheters1
DiMedtronic wins FDA breakthrough nod for Valiant stent graft-
DiMedtronic nabs accelerated review in U.S. for TAAA stent-
DiMedtronic plc: Medtronic Receives FDA Breakthrough Device Designation for Developing Stent Graft System to Treat ...1
07.10.Medtronic launches trial for extravascular ICD4
07.10.Medtronic plc: Medtronic Initiates Worldwide Pivotal Study of a New Approach to Treating Dangerously Fast Heart ...-
07.10.Medtronic appeals $24 patent loss to Supremes2
07.10.Medtronic submits rechargeable sacral neurostimulation device for FDA approval1
07.10.Medtronic bids for FDA approval of OAB/FI neuromodulation device-
07.10.Axonics down 6% on Medtronic filing for new overactive bladder device5
07.10.Medtronic files U.S. application for neurostimulation device for incontinence-
07.10.Medtronic Announces FDA Submission For InterStim Micro Neurostimulator275FRIDLEY (dpa-AFX) - Medtronic plc. (MDT) said Monday that it has filed a pre-market approval or PMA supplement with the United States Food and Drug Administration or FDA for approval of its...
► Artikel lesen
Seite:  Weiter >>
349 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
8,3,5